XML 26 R13.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Segment Information
 3 Months Ended
Mar. 29, 2024
Segment Reporting [Abstract]  
Segment Information SEGMENT INFORMATION
The Company operates and reports its results in business segments consisting of the Biotechnology, Life Sciences and Diagnostics segments. Operating profit represents total revenues less operating expenses, excluding nonoperating income and expense, interest and income taxes. Operating profit amounts in the Other segment consist of unallocated corporate costs and other costs not considered part of management’s evaluation of reportable segment operating performance. Intersegment amounts are not significant and are eliminated to arrive at consolidated totals.
Segment results are shown below ($ in millions):
 Three-Month Period Ended
March 29, 2024March 31, 2023
Sales:
Biotechnology$1,524 $1,864 
Life Sciences1,745 1,709 
Diagnostics2,527 2,376 
Total$5,796 $5,949 
Operating profit:
Biotechnology$325 $596 
Life Sciences235 321 
Diagnostics830 677 
Other(78)(77)
Total$1,312 $1,517